AU6265600A - Method for detection of early-onset alzheimer's disease - Google Patents
Method for detection of early-onset alzheimer's diseaseInfo
- Publication number
- AU6265600A AU6265600A AU62656/00A AU6265600A AU6265600A AU 6265600 A AU6265600 A AU 6265600A AU 62656/00 A AU62656/00 A AU 62656/00A AU 6265600 A AU6265600 A AU 6265600A AU 6265600 A AU6265600 A AU 6265600A
- Authority
- AU
- Australia
- Prior art keywords
- early
- disease
- detection
- onset alzheimer
- alzheimer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99201991 | 1999-06-22 | ||
| EP99201991 | 1999-06-22 | ||
| PCT/EP2000/005942 WO2000079000A1 (en) | 1999-06-22 | 2000-06-22 | Method for detection of early-onset alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6265600A true AU6265600A (en) | 2001-01-09 |
Family
ID=8240333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU62656/00A Abandoned AU6265600A (en) | 1999-06-22 | 2000-06-22 | Method for detection of early-onset alzheimer's disease |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6265600A (en) |
| WO (1) | WO2000079000A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0106051D0 (en) * | 2001-03-12 | 2001-05-02 | Isis Innovation | Diagnostic screens for alzheimer's disease |
| CN111057758A (en) * | 2019-12-23 | 2020-04-24 | 福州艾迪康医学检验所有限公司 | Primer and method for detecting PSEN1 gene mutation and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5986054A (en) * | 1995-04-28 | 1999-11-16 | The Hospital For Sick Children, Hsc Research And Development Limited Partnership | Genetic sequences and proteins related to alzheimer's disease |
| EP0785282A3 (en) * | 1996-01-19 | 1998-09-02 | Washington University School Of Medicine | Diagnosing and prognosing disease using sequences of the presenilin-1 gene |
| EP0811695A3 (en) * | 1996-06-06 | 1998-07-29 | Washington University | Mutant S182(PS-1) genes |
| WO1998051781A1 (en) * | 1997-05-14 | 1998-11-19 | Merck & Co., Inc. | Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
-
2000
- 2000-06-22 WO PCT/EP2000/005942 patent/WO2000079000A1/en active Application Filing
- 2000-06-22 AU AU62656/00A patent/AU6265600A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000079000A1 (en) | 2000-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001233299A1 (en) | Methods for treating alzheimer's disease | |
| AU1407399A (en) | Treatment for alzheimer's disease | |
| AU2610901A (en) | Predictive diagnostic for alzheimer's disease | |
| AU2002219824A1 (en) | Compositions and methods for diagnosing alzheimer's disease | |
| AU3891499A (en) | Diagnostic tests for alzheimer's disease | |
| AU2001278084A1 (en) | Model for alzheimer's disease and other neurodegenerative diseases | |
| AU2002220151A1 (en) | Method and system for the detection of heart disease | |
| AU2002363825A1 (en) | Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases | |
| AU2001236592A1 (en) | Methods for diagnosis of alzheimer's disease | |
| AU6932000A (en) | Tacrine derivatives for treating alzheimer's disease | |
| AU5131000A (en) | System for determining final position of teeth | |
| AU2001273661A1 (en) | Methods of screening for alzheimer's disease | |
| AU1405899A (en) | Treatment for alzheimer's disease | |
| AU5053296A (en) | Pharmaceutical agents for the treatment of Alzheimer's disease | |
| AU8346498A (en) | Method for diagnosing alzheimer disease | |
| AU3068899A (en) | Diagnostic assay for late-onset alzheimer's disease | |
| EP1181550A4 (en) | Methods for the identification of compounds for the treatment of alzheimer's disease | |
| AU2001248760A1 (en) | Preventives/remedies for alzheimer's disease | |
| AU9017098A (en) | Method for diagnosing alzheimer's disease | |
| AUPP870999A0 (en) | Method of treatment of equine disease | |
| AU3004000A (en) | Methods for the treatment of apolipoprotein e related diseases | |
| AU6265600A (en) | Method for detection of early-onset alzheimer's disease | |
| AU2002220372A1 (en) | Method for screening for inhibitors of alzheimer's disease | |
| AU6046900A (en) | Method for increasing the solubility of morphine and pharmaceutical compositionsprepared therefrom | |
| AU2002341044A1 (en) | Methods for detecting parkinson's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |